Biventricular Pacemakers in Patients With Heart Failure

2015 ◽  
Vol 35 (2) ◽  
pp. 20-28 ◽  
Author(s):  
Karen Leslie Cooper

Patients with heart failure may benefit from implantation of a biventricular pacemaker. This article discusses the indications for biventricular pacemaker implantation and the assessment of patients with biventricular pacemakers. Biventricular pacemakers require more assessments than do traditional single- or dual-chamber pacemakers.

EP Europace ◽  
2003 ◽  
Vol 4 (Supplement_2) ◽  
pp. B60-B60
Author(s):  
C. Suga ◽  
K. Matsumoto ◽  
T. Uchiyama ◽  
R. Kato ◽  
T. Tosaka ◽  
...  

2021 ◽  
Vol 14 (10) ◽  
pp. e245006
Author(s):  
Claire Seydoux ◽  
Philipp Suter ◽  
Denis Graf ◽  
Hari Vivekanantham

Pacing-induced cardiomyopathy (PICM) consists of heart failure (HF) associated with a drop in the left ventricular ejection fraction (LVEF) in the setting of high-burden right ventricular pacing, with presentation that may range from subclinical to severe. Time to manifestation can go from weeks to years after device implantation. Treatment typically consists in an upgrade to a cardiac resynchronisation therapy (CRT) or His bundle pacing (HisP). Several risk factors for PICM have been described and should be considered before pacemaker (PM) implantation, as thorough patient selection for de novo CRT or HisP, may preclude its manifestation. We present the case of an 82-year-old patient presenting with acute congestive HF and new severely reduced LVEF, 30 days following dual chamber PM implantation for high-grade atrioventricular block. Treatment with HF medication and upgrade to a CRT permitted rapid resolution of the symptoms and normalisation of the LVEF at 1-month follow-up.


1997 ◽  
Vol 23 ◽  
pp. S9
Author(s):  
Marcelo Vieira ◽  
Martino Martinelli-Filho ◽  
Sérgio Sidney da Costa ◽  
Caio C. Medeiros ◽  
Giovanni Cerri ◽  
...  

1995 ◽  
Vol 4 (2) ◽  
pp. 165-168
Author(s):  
CA Wackowski ◽  
PQ Bierman

Implantation of dual chamber pacemakers for symptoms associated with hypertrophic obstructive cardiomyopathy is being evaluated as an alternative treatment. The effectiveness of this intervention involves programming pacemaker parameters specific to the individual patient. We present a case of a patient diagnosed with hypertrophic obstructive cardiomyopathy who underwent dual chamber pacemaker implantation for symptoms refractory to medical therapy.


Sign in / Sign up

Export Citation Format

Share Document